Symphony Clinical Research? Announces VP Appointment
News Feb 21, 2013
Ms. Zarish is responsible for establishing and implementing the operational objectives and clinical processes employed by the global clinical team to deliver exceptional customer service with an unparalleled commitment to quality. She provides leadership to develop, grow and optimize the capabilities of Study Development, Study Management, Study Support and Document Management functions.
Ms. Zarish comes from Abbott Global Pharmaceutical Research & Development where she led an international team of study managers in the execution of clinical trial operations in multiple therapeutic areas. Kate was instrumental in the harmonization of global processes, tools and training programs for clinical study operations management, as well as standardizing study training for the monitoring staff. She maintains her certification as a Clinical Research Associate from ACRP.
“I am proud to be part of an organization that thinks about the patient first,” said Ms. Zarish. “The high standards we have established for in-home clinical services allows for trained health care professionals to ensure patient safety and to provide data with high integrity. It is the complete package for the patient, site and sponsor.”
Commenting on the new appointment, Nicki Norris, CEO states, “Kate’s role is critical in meeting the explosive demand for in-home clinical services. The pharmaceutical industry worldwide is beginning to realize the importance of reaching the intent-to-treat pool, accommodating debilitated patients, and retaining study participants all while completing trials on time. This is exactly what Symphony’s clinical services provide to our clients.”
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018